The Man Behind Rising 'Sun': Tale Of A Crorepati Druggist Who Borrowed Rs 10,000 To Start Business, Has A Net Worth Of Rs 1,46,090 Crore
Sun Pharmaceutical: Dilip Shanghvi, the 67-year-old Gujarati business tycoon, is the second-richest billionaire in the pharmaceutical sector after Cyrus Poonawalla. According to Forbes, Shanghvi's net worth is approximately Rs 1,46,090 crore. He is listed as the 97th richest person in the world by the magazine.
Jul 20, 2023, 22:27 PM IST
India's Sun Pharma Posts Near-30% Rise In Q4 Profit On Lower Input Costs
Shares of Sun Pharma settled 2.6 percent higher after the results and snapped six weeks of losses with a gain of 4.8 percent for the week.
May 27, 2023, 10:46 AM IST
Sun Pharma arm to acquire shares of Israeli firm Tarsius Pharma for $3 million
Indicative time period for completion of the acquisition is before September 15, 2018, Sun Pharma said.
Sep 10, 2018, 17:25 PM IST
Sun Pharma Q1 net loss at Rs 424.92 crore
The company had posted a net profit after taxes, share of profit/loss of associates, joint ventures and non-controlling interests of Rs 2,033.71 crore for the same period a year ago, Sun Pharmaceutical Industries said in a filing to the BSE.
Aug 11, 2017, 16:38 PM IST
Sun Pharma gets warning letter from USFDA over Halol unit
Drug major Sun Pharmaceutical Industries on Saturday said it has received a warning letter from the USFDA over violation of manufacturing norms in its facility at Halol in Gujarat.
Dec 19, 2015, 14:37 PM IST
Sun Pharma Q2 net profit dips 46% to Rs 1,107 crore
Drug major Sun Pharmaceutical Industries on Saturday reported 46.02 percent dip in its consolidated net profit at Rs 1,106.66 crore for the second quarter ended September 30, 2015 on account of lower sales, volatile currency movements and supply constraints.
Nov 07, 2015, 18:12 PM IST
Sun Pharma withdraws suit filed by Ranbaxy against USFDA
The lawsuit challenged FDA's revocation of Ranbaxy's tentative approvals for its generic versions of Nexium and Valcyte in the US.
Oct 09, 2015, 14:54 PM IST
Sun Pharma shareholders approve amalgamation scheme
Sun Pharmaceutical on Friday said court convened meeting of its shareholders has approved the scheme of amalgamation of Sun Pharma Global Inc with itself.
Jun 05, 2015, 14:58 PM IST
Sun Pharma, AstraZeneca seal distribution deal
Drug majors Sun Pharmaceutical and AstraZeneca Pharma India (AZPIL) on Tuesday said they have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in India.
Jun 02, 2015, 12:32 PM IST
Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A: Bankers
Sun Pharma, which has a market value of nearly $36 billion, is also interested in non-biotech complex generic medicine.
Apr 28, 2015, 11:13 AM IST
Sun Pharma shares bounce back, up nearly 2% at close
Shares of Sun Pharmaceutical Wednesday recovered nearly 2 percent to close at Rs 967.15 on BSE a day after the stock took a severe beating following Daiichi Sankyo selling its entire 9 percent stake in the company for Rs 20,025 crore.
Apr 22, 2015, 19:21 PM IST
Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma
The company was clarifying on speculations that Sanghvi, who holds 9.61 percent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from the Indian firm.
Apr 22, 2015, 12:04 PM IST
Daiichi Sankyo exits Sun Pharma; ends 7 years of tumultuous ride in India
The company, which had forayed into the growing Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, sold over 21 crore shares in Sun Pharma.
Apr 21, 2015, 14:42 PM IST
Japan's Daiichi completely exits Sun Pharma
Yesterday, Daiichi Sankyo Company Ltd had announced its decision to sell "the entire or part of its holdings of Sun Pharmaceutical shares..."
Apr 21, 2015, 12:40 PM IST
Daiichi Sankyo to offload stake in Sun Pharma worth Rs 22,000 cr
Japanese drug maker Daiichi Sankyo Monday said it board has approved selling a part or entire 9 percent holding worth over Rs 22,000 crore in Indian drug major Sun Pharmaceutical.
Apr 20, 2015, 18:53 PM IST
Ranbaxy stock to stop trading on exchanges from next week
Shares of Ranbaxy Laboratories will stop trading on BSE and NSE with effect from April 6 onwards as the company is merging with Sun Pharmaceutical Industries in a USD 4 billion deal.
Apr 04, 2015, 23:15 PM IST
Ranbaxy ends last trading day on bright note; surges over 5%
Shares of Ranbaxy Laboratories on Wednesday ended with strong gains on the last day of its trade, as the company is being merged with Sun Pharmaceutical in a USD 4 billion deal.
Apr 01, 2015, 19:07 PM IST
HC allows merger of Ranbaxy and Sun pharma
The Punjab and Haryana High Court Monday gave its nod to the merger of two Indian pharmaceutical companies - Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited.
Mar 09, 2015, 23:00 PM IST
Dilip Shanghvi to buy equity worth Rs 1,800 crore in Suzlon
Wind turbine maker Suzlon Energy has signed definitive agreements with Dilip Shanghvi Family and Associates (DSA) for equity investments of Rs 1,800 crore.
Feb 14, 2015, 08:42 AM IST
Sun Pharma falls 6% on reports of FDA inspection at Halol unit
Sun Pharmaceutical Industries on Thursday slumped as much as 6 percent, heading towards its biggest single day fall since March 16, 2012.
Sep 11, 2014, 11:10 AM IST
